3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
CNS
1
Conditions
Glioma
20
Glioblastoma
15
Brain Neoplasms
11
Neuroblastoma
4
Neoplasms
4
Astrocytoma
4
Sarcoma
3
Prostatic Neoplasms
2
Neurofibromatosis 1
2
Neoplastic Cells, Circulating
2
Meningioma
2
Lung Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Radiation Injuries
1
Polycystic Kidney, Autosomal Recessive
1
Pituitary Neoplasms
1
Pheochromocytoma
1
Parkinsonian Disorders
1
Paraganglioma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurofibromatosis-Noonan syndrome
1
Neurofibromatoses
1
Neoplasms, Germ Cell and Embryonal
1
Interventions
ziprasidone
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Tranexamic Acid
1
Tobramycin
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Nifedipine
1
Nafcillin
1
Molindone
1
Methylprednisolone
1
Lurasidone Hydrochloride
1
Labetalol
1
Haloperidol
1
Fosfomycin
1
Clozapine
1
Ciprofloxacin
1
Cidofovir
1
Cefepime
1
Bosentan
1
Blood Specimen Collection
1
Aminocaproic Acid
1
Amikacin
1
Alfentanil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemophilia A
×
Blood Specimen Collection
×
CNS
×
Clear all
NCT06147414
2026-04-23
DANNIgene
Assistance Publique - Hôpitaux de Paris
Recruiting
550 enrolled